Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities
| RNA Name | Mechanism of Action | Effect on Cancer | Reference |
|---|---|---|---|
|
SIRT2
mRNA |
NAD+-dependent deacetylase; modulates apoptosis via deacetylation of targets and ROS responses. | Often amplified/overexpressed in TNBC and promotes survival; SIRT2 loss sensitizes cells to ROS-induced apoptosis. | PMID: 27503926 |
External Database SearchDetailed Information
RNA Name:
SIRT2
Mechanism of Action:
NAD+-dependent deacetylase; modulates apoptosis via deacetylation of targets and ROS responses.
Effect on Cancer:
Often amplified/overexpressed in TNBC and promotes survival; SIRT2 loss sensitizes cells to ROS-induced apoptosis.
PMID:
27503926
|
|||
|
HRK
mRNA |
BH3-only pro-apoptotic Bcl-2 family member; binds Bcl-2/Bcl-xL to release Bax/Bak and promote mitochondrial apoptosis. | PMID: 30774992 | |
External Database SearchDetailed Information
RNA Name:
HRK
Mechanism of Action:
BH3-only pro-apoptotic Bcl-2 family member; binds Bcl-2/Bcl-xL to release Bax/Bak and promote mitochondrial apoptosis.
Effect on Cancer:
PMID:
30774992
|
|||
|
AIFM3
mRNA |
Mitochondrial oxidoreductase similar to AIF; upon release can mediate caspase-independent apoptosis via chromatin condensation and DNA fragmentation. | Overexpression in breast cancer linked to metastasis and poor prognosis. | PMID: 31088422 |
External Database SearchDetailed Information
RNA Name:
AIFM3
Mechanism of Action:
Mitochondrial oxidoreductase similar to AIF; upon release can mediate caspase-independent apoptosis via chromatin condensation and DNA fragmentation.
Effect on Cancer:
Overexpression in breast cancer linked to metastasis and poor prognosis.
PMID:
31088422
|
|||
|
AKT1
mRNA |
AKT1 (PKB?) is a serine/threonine kinase that promotes cell survival by phosphorylating/inactivating pro-apoptotic factors (BAD, FOXO), inhibiting caspase activation and promoting MDM2-mediated p53 degradation; isoform-specific effects exist in breast cancer. | AKT1 activation impairs apoptosis and promotes tumor initiation in breast cancer; isoform-specific roles affect therapy response in TNBC. | PMID: 31752925 |
External Database SearchDetailed Information
RNA Name:
AKT1
Mechanism of Action:
AKT1 (PKB?) is a serine/threonine kinase that promotes cell survival by phosphorylating/inactivating pro-apoptotic factors (BAD, FOXO), inhibiting caspase activation and promoting MDM2-mediated p53 degradation; isoform-specific effects exist in breast cancer.
Effect on Cancer:
AKT1 activation impairs apoptosis and promotes tumor initiation in breast cancer; isoform-specific roles affect therapy response in TNBC.
PMID:
31752925
|
|||
|
CASP3
mRNA |
Executioner caspase that cleaves multiple substrates to execute apoptosis following activation by initiator caspases. | Cleaved (active) caspase-3 in TNBC correlates with chemotherapy response and can be a marker of apoptosis. | PMID: 31949833 |
External Database SearchDetailed Information
RNA Name:
CASP3
Mechanism of Action:
Executioner caspase that cleaves multiple substrates to execute apoptosis following activation by initiator caspases.
Effect on Cancer:
Cleaved (active) caspase-3 in TNBC correlates with chemotherapy response and can be a marker of apoptosis.
PMID:
31949833
|
|||
|
TP53
mRNA |
TP53 encodes p53, a transcription factor that activates pro-apoptotic genes (BAX, PUMA/BBC3, NOXA) in response to DNA damage and stress, inducing mitochondrial apoptosis and cell-cycle arrest. | TP53 is frequently mutated in breast cancer, especially TNBC; mutant p53 alters apoptosis and is associated with therapy response and prognosis. | PMID: 32061310 |
External Database SearchDetailed Information
RNA Name:
TP53
Mechanism of Action:
TP53 encodes p53, a transcription factor that activates pro-apoptotic genes (BAX, PUMA/BBC3, NOXA) in response to DNA damage and stress, inducing mitochondrial apoptosis and cell-cycle arrest.
Effect on Cancer:
TP53 is frequently mutated in breast cancer, especially TNBC; mutant p53 alters apoptosis and is associated with therapy response and prognosis.
PMID:
32061310
|
|||
|
DLC1
mRNA |
Tumor-suppressor RhoGAP activity; restoration of DLC1 expression reduces pro-survival signaling and promotes apoptosis. | Curcumin restored DLC1 expression and promoted apoptosis in TNBC cell lines and xenografts. | PMID: 32725802 |
External Database SearchDetailed Information
RNA Name:
DLC1
Mechanism of Action:
Tumor-suppressor RhoGAP activity; restoration of DLC1 expression reduces pro-survival signaling and promotes apoptosis.
Effect on Cancer:
Curcumin restored DLC1 expression and promoted apoptosis in TNBC cell lines and xenografts.
PMID:
32725802
|
|||
|
BIRC2
mRNA |
Encodes cIAP1 which ubiquitinates caspases and inhibits apoptosis. | Overexpressed in TNBC and promotes chemoresistance. | PMID: 33673050 |
External Database SearchDetailed Information
RNA Name:
BIRC2
Mechanism of Action:
Encodes cIAP1 which ubiquitinates caspases and inhibits apoptosis.
Effect on Cancer:
Overexpressed in TNBC and promotes chemoresistance.
PMID:
33673050
|
|||
|
BIRC3
mRNA |
Encodes cIAP2; inhibits caspases and activates NF-?B pro-survival signaling. | Overexpressed in TNBC contributing to apoptosis resistance. | PMID: 33673050 |
External Database SearchDetailed Information
RNA Name:
BIRC3
Mechanism of Action:
Encodes cIAP2; inhibits caspases and activates NF-?B pro-survival signaling.
Effect on Cancer:
Overexpressed in TNBC contributing to apoptosis resistance.
PMID:
33673050
|
|||
|
TRPC5
mRNA |
Calcium channel; increased Ca2+ influx activates survival pathways and drug-resistance mechanisms. | promotes drug resistance in breast carcinoma via CaMKK?/AMPK?/mTOR pathway | PMID: 33426511 |
External Database SearchDetailed Information
RNA Name:
TRPC5
Mechanism of Action:
Calcium channel; increased Ca2+ influx activates survival pathways and drug-resistance mechanisms.
Effect on Cancer:
promotes drug resistance in breast carcinoma via CaMKK?/AMPK?/mTOR pathway
PMID:
33426511
|
|||